tom arkell cannabis researcher drive change photo

As the number of registered medical cannabis patients in Australia continues to grow, there is a pressing need to look critically at the current approach to cannabis and driving.

There is a very good body of evidence showing that levels of THC in the body do not correspond well to a person’s level of impairment, the amount of cannabis consumed or the time when it was consumed. This raises serious concerns around the suitability of the current random drug testing approach for patients who are using prescribed medical cannabis.

Tom Arkell

Postdoctoral Researcher: Lambert Initiative For Cannabinoid
Recent posts

Working and driving rights are human rights

If your prescribed medicine prevents you from driving and working, what does that mean for your human rights? The UK’s Cannabis Industry Council released a report this week into workplace issues for medicinal cannabis patients who are regarded as disabled under UK work, health and safety laws. Despite its specificity, it is a worthwhile read […]

Read more

Precarious working lives and longest days

Drive Change’s David Heilpern got some great soundbites in last Saturday morning and ABC News ran them on the hour, every hour, all day. This is the benefit of having elected reps in Victoria, WA and NSW bringing on topical parliamentary debates on cannabis law reform. Journalists will ring us to discuss this News, interview […]

Read more